Loading
Waystar Holding Corp. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 03 Mar 2026.
Waystar Holding Corp.: what insiders have been doing
This page follows insider dealings at Waystar Holding Corp. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. In the past year (18 October 2025 to 18 October 2026), 54 filings came from 23 insiders.
Both sides are active: 1 purchase worth €161k and 6 sales worth €7.0M, from 1 insider and 1 insider respectively. On balance, insiders were net sellers of €6.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants. Biggest ticket of the year: €1.9M, sold by Hawkins Matthew J. and made public on 7 October 2026 (0.044% of market cap).
Compared with its exchange (5,810 companies, median 19 filings), a count of 54 filings is above the norm. Over the whole record (from 2024), the tally stands at 1 purchase and 24 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 1.10 bn USD and net income at 112.1 m USD.
The most recent open-market purchase was published on 3 March 2026, 229 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
144
Thresholds
n/a
Buy Volume
€160,710
1 ops. · all time
Sell Volume
€2B
24 ops. · all time
Who traded when
BuySaleMatthew J. Hawkins9 sales
Bain Capital Investors LLC4 sales
Canada Pension Plan Investment Board3 sales
Derby LuxCo S.a r.l.3 sales
Moskowitz Paul G3 sales
Miller Melissa F. (Missy)2 sales
+3 other insiders
Since the insiders bought
- -0.2%Entry US$26.93 · Close 14 Oct 2026 US$26.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Waystar Holding Corp. Strong Buy (bullish), based on 22 analysts. Average price target: US$33.77.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,236 of 24,148 companies
51.2
score / 100
Value47
Quality56
FCF yld5.4%
Earn yld2.1%
EV/EBITDA17.3x
ROE3.8%
Gross mgn68%
Net mgn10%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$26.87
Analyst consensus
22 analystsStrong buy
US$28.00Target US$33.77(+26%)US$44.00
Income statement
RevenueUS$1.1B
Gross profitUS$751.1M68% margin
EBITDAUS$389.9M35% margin
Net incomeUS$112.1M11.2% margin
Valuation
PER (trailing)37.3x
PER (forward)14.3x
P/Book1.3x
Beta0.18
Balance sheet & cash
Market capUS$5.2B
Total debtUS$1.5B
Free Cash FlowUS$283.2M
Debt / Equity37%
Profitability & ownership
ROE3.8%
ROA3.4%
% insiders2.6%
% institutions113.1%
Last declaration on 7 October 2026
Declarations144 total
82,500 shares@ US$4.140.0069% mcap1.2% of flowCommon StockSEC:0001998256-26-000015:0
82,500 shares@ US$26.22870.044% mcap7.8% of flowCommon StockSEC:0001998256-26-000015:1
82,500 shares@ US$26.480.044% mcap80.2% of flowCommonSEC144:0001950047-26-010074
9,560 shares@ US$26.070.0050% mcap100.0% of flowCommon StockSEC:0002091511-26-000004:0
10,446 shares0Common StockSEC:0001257287-26-000005:0
10,446 shares0Common StockSEC:0001928634-26-000004:0
10,446 shares0Common StockSEC:0001946262-26-000004:0
10,446 shares0Common StockSEC:0001557593-26-000010:0
10,446 shares0Common StockSEC:0001199930-26-000007:0
10,446 shares0Common StockSEC:0001843139-26-000005:0
10,446 shares0Common StockSEC:0001577544-26-000012:0
390,625 shares0Common StockSEC:0002150055-26-000004:0
30,792 shares@ US$25.730.016% mcap9.3% of flowCommon StockSEC:0001998332-26-000008:0
6,754 shares@ US$25.730.0036% mcap64.5% of flowCommon StockSEC:0001735839-26-000006:0
30,287 shares@ US$25.730.016% mcap3.0% of flowCommon StockSEC:0001998256-26-000013:0
82,500 shares@ US$4.140.0071% mcap1.3% of flowCommon StockSEC:0001998256-26-000013:1
82,500 shares@ US$25.97070.044% mcap8.3% of flowCommon StockSEC:0001998256-26-000013:2
518,237 shares@ US$25.04670.27% mcap100.0% of flowCommonSEC144:0001950047-26-008119
162,112 shares0Common StockSEC:0001822516-26-000004:0
60,038 shares@ US$24.540.031% mcap100.0% of flowCommonSEC144:0001950047-26-008079
51,360 shares@ US$25.05340.027% mcap100.0% of flowCommonSEC144:0001950047-26-008070
60,038 shares@ US$4.140.0052% mcap1.0% of flowCommon StockSEC:0001998256-26-000011:2
22,462 shares@ US$4.140.0019% mcap0.4% of flowCommon StockSEC:0001998256-26-000011:0
22,462 shares@ US$25.03580.012% mcap2.2% of flowCommon StockSEC:0001998256-26-000011:1
60,038 shares@ US$25.01210.031% mcap5.8% of flowCommon StockSEC:0001998256-26-000011:3
25 of 144 declarations
About Waystar Holding Corp.
Waystar Holding Corp. (ticker: WAY) is a U.S.-based healthcare software company listed on the Nasdaq market in the United States. For French-speaking investors, it is best understood as a B2B infrastructure provider sitting at the center of healthcare payment workflows and revenue cycle management for hospitals, physician groups, and other care providers. The company was originally incorporated in Delaware in August 2019, adopted the Waystar Holding Corp. name in August 2023, and completed its initial public offering in June 2024. Its principal offices are co-located in Lehi, Utah, and Louisville, Kentucky, underscoring a dual operational footprint in two major U.S. health-tech hubs.
Waystar’s core business is a cloud-native software platform designed to simplify healthcare payments, reduce manual work, and improve providers’ financial performance. Its product suite spans patient access, claims management, payment processing, collections, denial prevention, and more recently AI-driven capabilities, including agentic and generative AI use cases. The company describes its enterprise-grade platform as processing more than 7.5 billion healthcare payment transactions annually, with over $2.4 trillion in annual gross claims, reaching approximately 60% of U.S. patients and one in three U.S. hospital discharges. These figures, highlighted by the company, illustrate the scale and embeddedness of its network, although investors should note they are company-reported metrics.
Read moreShow less
From a competitive standpoint, Waystar is positioned as a leading revenue cycle management platform in a fragmented but mission-critical category. Its differentiation is based on software depth, workflow integration, automation, and an expanding AI layer. The company has also built meaningful brand credibility through repeated Best in KLAS recognition and several innovation awards tied to AI capabilities. Another milestone was its addition to the S&P SmallCap 600 index in September 2025, which typically increases visibility among institutional investors and index-tracking funds.
Recent strategic developments have been particularly important. In July 2025, Waystar announced a definitive agreement to acquire Iodine Software for an enterprise value of $1.25 billion, a move aimed at strengthening its AI-powered transformation of healthcare payments. In 2026, the company continued to emphasize AI-led product expansion, including an expanded collaboration with Google Cloud in March and the launch in April of a solution targeting so-called “silent denials,” a large and often under-recognized source of provider revenue leakage. Overall, Waystar looks like a growth-oriented healthcare technology franchise with exposure to the U.S. market’s ongoing shift toward automated, data-driven payment infrastructure.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
